Human parvovirus B19 infection and antiphospholipid antibodies
Authors:
- Philipp von LandenbergPLPhilipp von Landenberg
- Hartwig W. LehmannHLHartwig W. Lehmann
- Susanne ModrowSMSusanne Modrow
- 1 April 2007
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 6 (5) , 278-285
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Parvovirus B19: a pathogen responsible for more than hematologic disordersVirchows Archiv, 2003
- The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysisJournal of Infection, 1998
- Most of the VP1 Unique Region of B19 Parvovirus Is on the Capsid SurfaceVirology, 1995
- The Structure of Human Parvovirus B19 at 8 Å; ResolutionVirology, 1994
- The prevalence of antibody to human parvovirus B 19 in England and WalesJournal of Medical Microbiology, 1988
- The Role of Parvovirus B19 in Aplastic Crisis and Erythema Infectiosum (Fifth Disease)The Journal of Infectious Diseases, 1986
- Experimental Parvoviral Infection in HumansThe Journal of Infectious Diseases, 1985
- HUMAN PARVOVIRUS, THE CAUSE OF ERYTHEMA INFECTIOSUM (FIFTH DISEASE)?The Lancet, 1983
- Occurrence of infection with a parvovirus-like agent in children with sickle cell anaemia during a two-year period.Journal of Clinical Pathology, 1982
- PARVOVIRUS-LIKE PARTICLES IN HUMAN SERAThe Lancet, 1975